Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

US expected to authorise mix-and-match Covid booster shots

 Federal regulators are expected to authorize the mixing and matching of COVID-19 booster doses this week in an effort to provide flexibility as the campaign for extra shots expands. The upcoming announcement by the Food and Drug Administration is likely to come along with authorization for boosters of the Moderna and Johnson & Johnson shots and follows the OK for a third dose for the Pfizer vaccine for many Americans last month. The move was previewed Tuesday by a U.S. health official familiar with the matter who was not authorized to speak publicly ahead of the announcement. The FDA was expected to say that using the same brand for a booster was still preferable, especially for the mRNA vaccines from Pfizer and Moderna that have proved most effective against the coronavirus. The agency was still finalizing guidance for the single-shot J&J vaccine. Preliminary results from a government study of different booster combinations found an extra dose of any type revs up levels of ..
19-10-2021
Bigul

Pfizer Ltd - 500680 - Shareholding for the Period Ended September 30, 2021

 Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
18-10-2021

COVID-19: South Africa to vaccinate 12 to 17-year-olds

 The Pfizer vaccine, which has been approved by the South African Health Products Regulatory Authority, will be administered to the age group. But the children and teenagers will only receive one dose at this stage, unlike adults who have been receiving two doses over a period.
16-10-2021
Bigul

Pfizer Ltd - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated October 9, 2021, issued by KFin Technologies Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended September 30, 2021. We request you to take the same on record.
14-10-2021
Bigul

PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39 (3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received request for issue of duplicate Share Certificate(s) from the Shareholder(s) as per the details enclosed.
08-10-2021

Pfizer asks US govt to allow Covid vaccine shots for kids ages 5 to 11

 Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today's age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities. Pfizer announced in a tweet that it had formally filed its application with the Food and Drug Administration. Now the FDA will have to decide if there's enough evidence that the shots are safe and will work for younger children like they do for teens and adults. An independent expert panel will publicly debate the evidence on Oct. 26. One big change: Pfizer says its research shows the younger kids should get a third of the dose now given to everyone else. After their second .
07-10-2021
Bigul

Pfizer Ltd - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39 (3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received request for issue of duplicate Share Certificate(s) from the Shareholder(s) as enclosed.
06-10-2021

Pfizer vaccine effective against Covid hospitalisations for 6 months: Study

 Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months: Lancet study
05-10-2021

European Union watchdog backs Pfizer booster for over-18s

 Rare cases of myocarditis, an inflammation of the heart muscle, have been reported in people who have taken the Pfizer vaccine, especially in young men.
04-10-2021
Bigul

Pfizer Ltd - 500680 - Sale Of Pfizer Limited'S Upjohn Business To Mylan Pharmaceuticals Private Limited

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), we hereby inform you that the Company has entered into a business transfer agreement ('BTA') with Mylan Pharmaceuticals Private Limited ('Mylan') to transfer certain primarily off-patent branded and generic established medicines business ('Upjohn Business') as a going concern to Mylan for a consideration of INR 180.48 Crore. The consideration for the transfer of the Upjohn Business is supported by valuation reports issued by two independent valuers. The valuation reports have been reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company. Completion of the transaction is subject to fulfilment of certain conditions (including regulatory approvals) as set out in the BTA. The Upjohn Business comprises of six brands which includes Lyrica, Viagra, Celebrex, Amlogard, Daxid and Dilantin
01-10-2021
Next Page
Close

Let's Open Free Demat Account